LUCASBIO
HOME
Contact Us
ABOUT
- Company
- Leadership
- Mission & Vision
- Key Personnel
- Advisory Committee Member
- History
- Locations
TECHNOLOGY
- What is Cell Therapy
- Patents
- Publicaitons
- Clinical Trials
PIPELINE
- Pipeline Overview
- Immune Cell Therapy
- Stem Cell Therpay
CONTACT
- News & Events
- Contact Us
ABOUT
Company
Leadership
Mission & Vision
Key Personnel
Advisory Committee Member
History
Locations
TECHNOLOGY
What is Cell Therapy
Patents
Publicaitons
Clinical Trials
PIPELINE
Pipeline Overview
Immune Cell Therapy
Stem Cell Therpay
CONTACT
News & Events
Contact Us
KOR
/
ENG
TECHNOLOGY
ABOUT
TECHNOLOGY
PIPELINE
CONTACT
Patents
What is Cell Therapy
Patents
Publicaitons
Clinical Trials
TECHNOLOGY
Patents
TECHNOLOGY
Patents
LucasBio’s Current Patents.
게시판 검색
Patents LIST
No.
Patent
Registration No.
Registration Date
Country
7
Method for high-purity separation of maternal-derived stromal cells and composition for preventing or treating immune diseases including stromal cells isolated therefrom
Registration No. : 10-2022-0075231
Registration Date : 2022.06.21
Country : Application (Rep. of Korea)
10-2022-0075231
2022.06.21
Application (Rep. of Korea)
6
Method for enrichment and expansion of virus antigen-specific T cells
Registration No. : 20180305665
Registration Date : 2022.07.02
Country : Decision on Registration (U.S)
20180305665
2022.07.02
Decision on Registration (U.S)
5
Method for enrichment and expansion of virus antigen-specific T cells
Registration No. : 06697076
Registration Date : 2020.04.27
Country : Registration (Japan)
06697076
2020.04.27
Registration (Japan)
4
Method for enrichment and expansion of virus antigen-specific T cells
Registration No. : 10-1867942
Registration Date : 2018.06.08
Country : Registration (Rep. of Korea)
10-1867942
2018.06.08
Registration (Rep. of Korea)
3
Composition for preventing or treating B-cell lymphoma comprising IL-21 expressing mesenchymal stem cells
Registration No. : 14/671,626
Registration Date : 2018.12.18
Country : Registration (U.S)
14/671,626
2018.12.18
Registration (U.S)
2
Composition for preventing or treating B-cell lymphoma comprising IL-21 expressing mesenchymal stem cells
Registration No. : 10-1723786
Registration Date : 2017.03.31
Country : Registration (Rep. of Korea)
10-1723786
2017.03.31
Registration (Rep. of Korea)
1
Mesenchymal stem cell introduced with a nucleotide sequence encoding TGFβ and use thereof
Registration No. : 10-1301262
Registration Date : 2013.08.19
Country : Registration (Rep. of Korea)
10-1301262
2013.08.19
Registration (Rep. of Korea)
SEARCH
Search target
제목
내용
제목+내용
글쓴이
글쓴이(코)
search word
necessary
Search
Close
ABOUT
Company
Leadership
Mission & Vision
Key Personnel
Advisory Committee Member
History
Locations
TECHNOLOGY
What is Cell Therapy
Patents
Publicaitons
Clinical Trials
PIPELINE
Pipeline Overview
Immune Cell Therapy
Stem Cell Therpay
CONTACT
News & Events
Contact Us
Address. 222, Banpo-daero, Seocho-gu, Seoul, 06591 Korea The Catholic University of Korea Sungeui
Tel. +82-2-532-2520 ㅣ Fax. +82-2-534-2520
COPYRIGHT(c) 2020 LUCASBIO. ALL RIGHTS RESERVED. Email :
lucasbio@lucasbio.com
Address. 222, Banpo-daero, Seocho-gu, Seoul, 06591 Korea The Catholic University of Korea Sungeui
Tel. +82-2-532-2520 ㅣ Fax. +82-2-534-2520
COPYRIGHT(c) 2020 LUCASBIO. ALL RIGHTS RESERVED.
Email :
lucasbio@lucasbio.com
상단으로